Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Headache

CTech 24/7

  • REE Automotive cutting 50% of staff after $70M loss
  • Merlin Ventures raises $75 million to back next wave of Israeli cybersecurity startups
  • Full list of Israeli startup M&As in 2025
  • Canopy appoints Avi Revivo as CTO and GM Israel
More stories in CTech

Headache

1 stories about Headache
  • Teva. Photo: Sivan Farage

    Teva Discontinues Development of Cluster Headache Drug

    24.04.19|Tzally GreenbergUnder Teva’s brand name Ajovy, fremanezumab has already been approved in the U.S. and Europe as a preventative migraine treatment

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive